Literature DB >> 14769841

Cyclooxygenase-2 expression and its relationship with proliferation of colorectal adenomas.

Takanobu Sato1, Keigo Yoshinaga, Satoshi Okabe, Takuya Okawa, Tetsuro Higuchi, Masayuki Enomoto, Touichirou Takizawa, Kenichi Sugihara.   

Abstract

BACKGROUND: Cyclooxygenase (COX)-2 may be linked to carcinogenesis. In the previous study, we examined COX-2 expression immunohistochemically in 95 adenomas and reported a significant correlation between its expression and the grade of dysplasia. To clarify the correlation between COX-2 expression and cell proliferation, we investigated Ki-67 labeling index using immunohistochemistry and its correlation with COX-2 expression.
METHODS: Immunohistological staining for Ki-67 antigen was performed on 95 colorectal adenomas previously reported.
RESULTS: The Ki-67 labeling index was significantly higher in the high-COX-2 group than in the low-COX-2 and negative groups in adenomas with moderate (44.5 +/- 6.4% vs 33.0 +/- 2.6%, 39.0 +/- 6.2%; P = 0.01, P < 0.001, respectively) or severe dysplasia (47.2 +/- 7.6% vs 40.3 +/- 7.2%, 35.0 +/- 5.4%; P = 0.02, P = 0.005, respectively). There was no correlation between Ki-67 labeling index and COX-2 expression in mild dysplasia.
CONCLUSIONS: These results suggest that COX-2 may play a causal role in cell proliferation in carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14769841     DOI: 10.1093/jjco/hyg114

Source DB:  PubMed          Journal:  Jpn J Clin Oncol        ISSN: 0368-2811            Impact factor:   3.019


  8 in total

1.  Odontogenic epithelial proliferation is correlated with COX-2 expression in dentigerous cyst and ameloblastoma.

Authors:  Mohammed Amjed Alsaegh; Hitoshi Miyashita; Takahiro Taniguchi; Sheng Rong Zhu
Journal:  Exp Ther Med       Date:  2016-12-01       Impact factor: 2.447

2.  Prognostic role of IRS-4 in the survival of patients with pancreatic cancer.

Authors:  Miguel A Ortega; Leonel Pekarek; Cielo Garcia-Montero; Oscar Fraile-Martinez; Miguel A Saez; Angel Asúnsolo; Miguel A Alvarez-Mon; Jorge Monserrat; Santiago Coca; M Val Toledo-Lobo; Natalio García-Honduvilla; Agustin Albillos; Julia Buján; Melchor Alvarez-Mon; Luis G Guijarro
Journal:  Histol Histopathol       Date:  2022-02-09       Impact factor: 2.303

3.  Expression of insulin-like growth factor binding protein-2 in gastric carcinoma and its relationship with cell proliferation.

Authors:  Liang-Hui Shi; Xiao-Qun Zhu; Guo-Hai Zhao; Ya-Bin Xia; Yi-Sheng Zhang
Journal:  World J Gastroenterol       Date:  2006-10-21       Impact factor: 5.742

4.  Expression of IGFBP2 in gastric carcinoma and relationship with clinicopathologic parameters and cell proliferation.

Authors:  Lihua Zhang; Wenbin Huang; Jieyu Chen; Xiaojun Zhou; Zhenfeng Lu; Hangbo Zhou
Journal:  Dig Dis Sci       Date:  2006-12-15       Impact factor: 3.487

5.  Relation of the expression of cyclooxygenase-2 in colorectal adenomas and adenocarcinomas to angiogenesis and prognosis.

Authors:  Yoon Dae Han; Young Ki Hong; Jung Gu Kang; Yoon Jung Choi; Chan Heun Park
Journal:  J Korean Soc Coloproctol       Date:  2010-10-31

6.  EGF receptor and COX-1/COX-2 enzyme proteins as related to corresponding mRNAs in human per-operative biopsies of colorectal cancer.

Authors:  Annika Gustafsson Asting; Ava Farivar; Britt-Marie Iresjö; Helena Svensson; Bengt Gustavsson; Kent Lundholm
Journal:  BMC Cancer       Date:  2013-10-30       Impact factor: 4.430

7.  Immunoexpression of the COX-2, p53, and caspase-3 proteins in colorectal adenoma and non-neoplastic mucosa.

Authors:  Renan Brito Nogueira; Andréa Rodrigues Cordovil Pires; Thélia Maria Santos Soares; Simone Rabello de Souza Rodrigues; Mariane Antonieta Menino Campos; Giovanna Canato Toloi; Jaques Waisberg
Journal:  Einstein (Sao Paulo)       Date:  2013-12

8.  Deletion of cyclooxygenase-2 inhibits K-ras-induced lung carcinogenesis.

Authors:  Yong Pan; Yan Jiang; Lin Tan; Murali K Ravoori; Mihai Gagea; Vikas Kundra; Susan M Fischer; Peiying Yang
Journal:  Oncotarget       Date:  2015-11-17
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.